NJ Sues Insys Over Opioid Drug Push, Calls Conduct 'Evil'
New Jersey has slammed Insys Therapeutics Inc. with a civil lawsuit accusing it of trying to squeeze more profits from its opioid-fentanyl drug Subsys by marketing it for general chronic pain treatment...To view the full article, register now.
Already a subscriber? Click here to view full article